Separate the signal from the noise

Dr. Harry Saag is an internal medicine physician with deep experience in virtual care and population health. As Co-founder and CEO of Signal Health, he aims to provide personalized, convenient care to reduce preventable heart disease.

Before co-founding Signal Health, Dr. Saag was the National Medical Director of Virtual Care at Walgreens. A serial entrepreneur, he also founded a company focused on addressing social determinants of health for underserved populations. Prior to that, he served as Medical Director for Ambulatory Quality and Network Integration at NYU Langone Health.

Dr. Saag remains clinically active as both a virtual care physician and a primary care physician in his community. His academic work has been published in journals such as JAMA, JAMA Internal Medicine, and the Journal of General Internal Medicine.

Dr. Gregory Katz is a board-certified cardiologist at NYU Langone Health and a nationally recognized expert in cardiovascular prevention. As co-founder and Chief Medical Officer of Signal Health, he brings his deep clinical expertise and passion for prevention to help people understand and lower their risk of heart disease. He oversees all clinical protocols to ensure you are receiving best-in-class cardiology care at Signal Health.

Dr. Katz is an Assistant Professor at NYU Grossman School of Medicine and an Associate Program Director of the NYU Internal Medicine Residency Program.

Beyond the clinic, Dr. Katz serves in several national leadership roles including on the American College of Cardiology's National Council on Diabetes and Cardiometabolic Disease. He also is a leader in medical education co-hosting the Beyond Journal Club podcast, a collaboration between the New England Journal of Medicine and CoreIM. He also writes a widely read newsletter on cardiovascular health, evidence-based care, and the future of medicine, at gregorykatz.substack.com.

Dr. Anaïs Hausvater is a board-certified cardiologist at NYU Langone Health. She is an expert in women's cardiovascular health and managing heart disease in pregnancy and postpartum. As an advisor at Signal Health, Dr. Hausvater brings deep clinical expertise related to the cardiovascular risk factors that uniquely affect women including gynecologic disorders such as PCOS and premature menopause. Dr. Hausvater helps guide the clinical protocols at Signal Health to ensure we are considering how "signals" of early heart disease risk might look different in men and women, and how to optimize women's heart health at every stage of life.

Dr. Hausvater is an Assistant Professor at NYU Grossman School of Medicine, serves as co-director of the Cardio-Obstetrics Research Program and the Postpartum Cardiovascular Health Program. Dr. Hausvater has received funding from the NIH to study heart diseases that predominately or uniquely affect women including chronic chest pain syndromes and heart attacks with open arteries. Her work has been published in high impact journals, such as NEJM, JACC, and Circulation.